APA

Fandy T. E., Herman J. G., Kerns P., Jiemjit A., Sugar E. A., Choi S., Yang A. S., Aucott T., Dauses T., Odchimar-Reissig R., Licht J., McConnell M. J., Nasrallah C., Kim M. K. H., Zhang W., Sun Y., Murgo A., Espinoza-Delgado I., Oteiza K., Owoeye I., Silverman L. R., Gore S. D. & Carraway H. E. (20091027). Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. : Blood.

Chicago

Fandy Tamer E, Herman James G, Kerns Patrick, Jiemjit Anchalee, Sugar Elizabeth A, Choi Si-Ho, Yang Allen S, Aucott Timothy, Dauses Tianna, Odchimar-Reissig Rosalie, Licht Jonathan, McConnell Melanie J, Nasrallah Chris, Kim Marianne K H, Zhang Weijia, Sun Yezou, Murgo Anthony, Espinoza-Delgado Igor, Oteiza Katharine, Owoeye Ibitayo, Silverman Lewis R, Gore Steven D and Carraway Hetty E. 20091027. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. : Blood.

Harvard

Fandy T. E., Herman J. G., Kerns P., Jiemjit A., Sugar E. A., Choi S., Yang A. S., Aucott T., Dauses T., Odchimar-Reissig R., Licht J., McConnell M. J., Nasrallah C., Kim M. K. H., Zhang W., Sun Y., Murgo A., Espinoza-Delgado I., Oteiza K., Owoeye I., Silverman L. R., Gore S. D. and Carraway H. E. (20091027). Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. : Blood.

MLA

Fandy Tamer E, Herman James G, Kerns Patrick, Jiemjit Anchalee, Sugar Elizabeth A, Choi Si-Ho, Yang Allen S, Aucott Timothy, Dauses Tianna, Odchimar-Reissig Rosalie, Licht Jonathan, McConnell Melanie J, Nasrallah Chris, Kim Marianne K H, Zhang Weijia, Sun Yezou, Murgo Anthony, Espinoza-Delgado Igor, Oteiza Katharine, Owoeye Ibitayo, Silverman Lewis R, Gore Steven D and Carraway Hetty E. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies. : Blood. 20091027.